Sarah Cannon Research Institute, Nashville
SCRI Oncology Partners, Nashville
Tennessee Oncology, PLLC - Elliston Place Plaza Medical Oncology & Hematology, Nashville
외 9개

18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07421700

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

피험자 모집 중1상

Sarah Cannon Research Institute, Nashville

18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07277413

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

피험자 모집 중1상

Urology Associates, P.C., Nashville

18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07206225

DESTINY-PANTUMOUR04

피험자 모집 중관찰 연구

Research Site, Nashville

18세 ~ 130세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07124000

A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

피험자 모집 중3상

Tennessee Oncology, PLLC - Elliston Place Plaza Medical Oncology & Hematology ( Site 0831), Nashville

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07419295

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

피험자 모집 중3상

Sarah Cannon Research Institute, Nashville
SCRI Oncology Partners, Nashville
Tennessee Oncology, Nashville

18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07218380

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

피험자 모집 중1/2상

Sarah Cannon Research Institute, Nashville

18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT05267626

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

피험자 모집 중1상

SCRI, Nashville
Vanderbilt-Ingram Cancer Center, Nashville

18세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT07217171

First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors

피험자 모집 중1상

Sarah Cannon Research Institute, Nashville

18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT06644755

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

피험자 모집 중2상

Urology Associates, PC, Nashville

18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06567743

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

피험자 모집 중2상

Urology Associates PC, Nashville

18세 이상 · 모든 성별 · 2026. 8. 24. 업데이트됨 · NCT05951179

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

피험자 모집 중2/3상

Research Site, Nashville

18세 이상 · 모든 성별 · 2026. 8. 20. 업데이트됨 · NCT07129993

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

피험자 모집 중1상

Sarah Cannon and HCA Research Institute, Nashville
Tennessee Oncology, Nashville
Vanderbilt University Medical Center, Nashville

18세 이상 · 모든 성별 · 2026. 8. 20. 업데이트됨 · NCT05614739

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

피험자 모집 중3상

Vanderbilt Breast Center at One Hundred Oaks, Nashville
Vanderbilt University/Ingram Cancer Center, Nashville

18세 이상 · 모든 성별 · 2026. 8. 18. 업데이트됨 · NCT07097142

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

피험자 모집 중1/2상

Sarah Cannon Research Institute Oncology Partners (SCRI-Nashville), Nashville

18세 이상 · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT05592626

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

피험자 모집 중1/2상

Urology Associates, P.C., Nashville
Vanderbilt Univerity Medical Center, Nashville

18세 이상 · 모든 성별 · 2026. 8. 7. 업데이트됨 · NCT04752722

Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2

피험자 모집 중관찰 연구

Vanderbilt University Medical Center, Nashville

18세 이상 · 모든 성별 · 2026. 7. 31. 업데이트됨 · NCT07225127

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

피험자 모집 중2/3상

SCRI Oncology Partners, Nashville
Local Institution - 0084, Nashville

18세 이상 · 모든 성별 · 2026. 7. 29. 업데이트됨 · NCT07106762

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

피험자 모집 중2상

SCRI - TriStar Medical Group Children's Specialists, Nashville
SCRI Oncology Partners, Nashville

8세 이상 · 모든 성별 · 2026. 7. 27. 업데이트됨 · NCT05503797

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

피험자 모집 중3상

Research Site, Nashville

18세 이상 · 모든 성별 · 2026. 7. 22. 업데이트됨 · NCT07720284

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

피험자 모집 중1상

US Oncology Research LLC, Nashville

18세 이상 · 모든 성별 · 2026. 7. 6. 업데이트됨 · NCT04389632

Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.

피험자 모집 중

Vanderbilt University Medical Center, Nashville

18세 ~ 88세 · 모든 성별 · 2026. 7. 2. 업데이트됨 · NCT06394869

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

피험자 모집 중1상

Sarah Cannon Research Institute (SCRI) Oncology Partners, Nashville
Vanderbilt University Medical Center, Nashville

18세 이상 · 모든 성별 · 2026. 2. 13. 업데이트됨 · NCT06778863

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

피험자 모집 중관찰 연구건강한 지원자 환영

Vanderbilt-Ingram Cancer Center, Nashville

40세 이상 · 모든 성별 · 2026. 1. 20. 업데이트됨 · NCT05366881

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

피험자 모집 중관찰 연구

Massive Bio SYNERGY-AI site, Nashville

전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774

다른 도시의 방광암 시험

Nashville의 다른 연구

ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.